Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study

Dogan V., Basaran O., Beton O., Tekinalp M., Bolat I., Kalaycioglu E., ...More

CORONARY ARTERY DISEASE, vol.27, no.6, pp.497-503, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 6
  • Publication Date: 2016
  • Doi Number: 10.1097/mca.0000000000000389
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.497-503
  • Keywords: anticoagulant therapy, coronary artery disease, nonvalvular atrial fibrillation, RHYTHM MANAGEMENT, THERAPY, RISK, ANTICOAGULATION, INTERVENTION, PREVALENCE, MORTALITY, REGISTRY, ASPIRIN, STROKE
  • Eskisehir Osmangazi University Affiliated: No


Background Nonvalvular atrial fibrillation (NVAF) frequently coexists with coronary artery disease (CAD). However, the optimal antithrombotic strategy for patients with concomitant CAD and NVAF is controversial. The aim of this study is to assess the prevalence of CAD with NVAF and to determine antithrombotic treatment options in patients with or without a history of CAD.